Google TrendMAX CASTER (200+) — Moose Def. Max Caster At TNA Bound For Glory 2026
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Targeted therapy reduces" (30 stories)

Top Headline Story

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype
Lead StoryUCLA Healthworld
May 31

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQZmhUZDdFZW9nb3pBd1poa0pmSFM0eVRlMU9HYmxGSkwxQk5fMnJQUUlrSEpuOEJIT0NRS3dFSHRZY3d0c1VUeWtrb3NkRk41VjVMME1KQms1RGhWbGtvNmJjWU5PN2NTdGdjTk1GamZjVGwxRDFFdmJ3Y1h1UmxxekZSN0tlWE9vTXRhRTdLUVdBNl9DVnFDemxQSlpLMTltTFE?oc=5" target="_blank">Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype</a>  <font color="#6f6f6f">UCLA Health</font>

Real-time search volume
200+22m ago

max caster

Moose Def. Max Caster At TNA Bound For Glory 2026

200+22m ago

prince harry family photo story

Prince Harry Reveals the Photo He Took of Archie and Lilibet That ‘Fills My Heart’

500+32m ago

kelley knockel

1 dead, multiple injured after pair of motorcycle crashes involving deer in Iowa

200+32m ago

torino vs udinese

Torino vs Udinese: Italian Serie A stats & head-to-head

Search Results for "Targeted therapy reduces"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer
Memorial Sloan Kettering Cancer Centerworld

Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOeVNEaVdMTzYyU3FPamJWVjJadlZPVWZld1IzVzRNcjhsMld2dW5YRVY4NzFQSnVEMWR2MGJRZFNIeWVmMWp6MzBVZVFPZHBreW5wMnB4aHlCTVZQNTdONGZFdXl2U1cxcGhtNm9ONXJrN2JIZDVwN3ZMQXBoUDNjUm8wNkF3SW5WX3RBQmJlbTlLTFZIYlhGdUlTOWlSMkVyeEluejBLUWhiT2t5Znc?oc=5" target="_blank">Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Transforming AML Therapy: Lower-Intensity Regimens, Targeted Triplets, and Upfront Molecular Subtyping
Targeted Oncologygeneral

Transforming AML Therapy: Lower-Intensity Regimens, Targeted Triplets, and Upfront Molecular Subtyping

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQVnhrMC1ndWhDaXNRNGJDVFRtLWV0aFdnUm4wQXh4NHN1X2Q1MEdFdkxYYm9mUmJmNWNaaHlRelYwdXJXMzlQRG5MQUpnY3luakwxcUhvM1lGUnNPcjN1dzB4aDcwRFdLQjJTdnBuZ291d3NuZ3FYS1Q0TEtaNGh5ajhKamRTOTUxYVk1SF93Yw?oc=5" target="_blank">Transforming AML Therapy: Lower-Intensity Regimens, Targeted Triplets, and Upfront Molecular Subtyping</a>  <font color="#6f6f6f">Targeted Oncology</font>

Potassium channel-targeted therapy in reducing vascular complications in diabetes mellitus: novel insights
Frontiersgeneral

Potassium channel-targeted therapy in reducing vascular complications in diabetes mellitus: novel insights

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPYUFYQTFRLXNJdEFsVTMyWEdtRkdHVVJHakMtZWhtZ1dhbGloSkNrdjFoWGNJc3JTeUg3d1RCeXhnWXFaYmZFcUdoY3BTQ0Z5MmpLakNJU0NsV1p5dDROSVE4YUtNSGJTTzJheXZUVmc3TTFxUWRYcmNNd0x4c2F1TFFzdkNCcnJ3eGYxZ1l5Q09aN3hn?oc=5" target="_blank">Potassium channel-targeted therapy in reducing vascular complications in diabetes mellitus: novel insights</a>  <font color="#6f6f6f">Frontiers</font>

“Smart” Strategy of Up-front Targeted Therapy Reduces Need for Chemo in LBCL
OncLivegeneral

“Smart” Strategy of Up-front Targeted Therapy Reduces Need for Chemo in LBCL

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmdqMm9yYnhiWWJKY1BlY1JETkhXVnBOTV92ZmlHUWlLeUYyak1iMm9XcmlDVFpfV09uVzJ3SmFEMkJTWm9jdkVMM1pqM1FuWUUxYjY5UXNScjE5eFFDVkZsaFREV3JtU2ZHN1dXLTZnNnhRUjdlNDhaaTFwTS0xZnFOMWdCcl9vLTRIVXB6NXVGQV9ZS2gyVkl3QWROSGtwME1YbXNoQQ?oc=5" target="_blank">“Smart” Strategy of Up-front Targeted Therapy Reduces Need for Chemo in LBCL</a>  <font color="#6f6f6f">OncLive</font>

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering
American Heart Association Journalstech

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5IZDBCQi1PRFVBUzNsNnE1LTBCREFCUDY3UjFNME9zcDBaMzV1MUZ4RFVsdXpTVjBkNlJsMXBaOXZodVpUanFfWmNLTDNqVXlYcW01Q0F4MEJVSnRQLUJtTDV0TFBEWEt1R0g1Wkp3?oc=5" target="_blank">New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
BioSpacegeneral

Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOWmpRdEJWY0xoVGZ0MlRGa1BWUE54ZlBBZkZ5SDJfU2V1aXFkUUhaaTFkNHFUSkVKZjJ5TjY3MjlRTjV3ejc0eVFhUmlES014M0drcnp2T0JNMU1BdjZybEFqX2kwUW9vVFVja1F0U3ZEYnlXV1pDLW45WEpqUTNfTnRrSEpJQUxhTUVMOTlyeUdBOWktS002dllhZWI2V0VDdW1rRnkwSm1mZ3dTYXBNMURSTHdjekZHSmxuTTdwYXh6c0E?oc=5" target="_blank">Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod</a>  <font color="#6f6f6f">BioSpace</font>

Targeted Therapy for ANCA Associated Vasculitis: Where Have We Been? - Zeng - 2026 - Nephrology
Wiley Online Librarygeneral

Targeted Therapy for ANCA Associated Vasculitis: Where Have We Been? - Zeng - 2026 - Nephrology

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE01enQ2cmxtVEFvaGl6SkdJTGFXZEJmMkFIM2ttSDdVeEdJRVBsWk5BeHVMM2ZLZ1JRQ0U0RnV3X0QzdXlJY2hCSlRpVUgtbWdmcVJVWG1PNjNrekpXc2NvNjBqdVJtOW9UaUE?oc=5" target="_blank">Targeted Therapy for ANCA Associated Vasculitis: Where Have We Been? - Zeng - 2026 - Nephrology</a>  <font color="#6f6f6f">Wiley Online Library</font>

Targeting Lynch Syndrome to Reduce Colorectal Cancer Risk
University of Colorado Anschutzgeneral

Targeting Lynch Syndrome to Reduce Colorectal Cancer Risk

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOZ2piOVVhNzhIOFhzSkVIaGtSamRISHlaSnhhWjNqQ0gxbXluVGczOXpweUNWSV9uTGtUMk1ScS03eFZBQWY4cElDMUhVQXhQU3F6Q1pwRE53aGR4ZkhDdFEyLURhYVBtWDhGNGFEUlAtWF9sSkpxUHhJN0djNmtsYjBudWpxd9IBlgFBVV95cUxPTUhrZlBsb2RoTVEzTndhUkhCZEtHTTQ4R2xSOVVxY2dBUWVXMGswNnMzWVZ4NENqTV9YVElqdVhQOXh1RUY2bnQydnlzMG80T2FLTkZlckpKbnVELWltd3NwRFZiLUUtbk40TEdGS1lzVTN0R1JxYkJJTk9vb2w5MTN1b0xpb2k3eVAwUGdpOVdkLXVYb2c?oc=5" target="_blank">Targeting Lynch Syndrome to Reduce Colorectal Cancer Risk</a>  <font color="#6f6f6f">University of Colorado Anschutz</font>

IMAVVY approved as first targeted therapy for wAIHA
PharmaTimestech

IMAVVY approved as first targeted therapy for wAIHA

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNN3JmRDZDSzdHVVlUbU0xeElqWkZsSThiNkl3Zm93RUxvdFQ1bWN5dE1na2ZHWjBPT0JSX0JydklMOC13UTRyZ3lYblV0TGxpbzRpSW02dzEtWnRmVTlNSVZ3NTRDUmJrQkhMTTVvOTgxTVJZYThnY25UaFFKeXV5Qzc5RDdRcXlx?oc=5" target="_blank">IMAVVY approved as first targeted therapy for wAIHA</a>  <font color="#6f6f6f">PharmaTimes</font>

New Lung Cancer Treatments Aim To Reduce Deaths and Improve Lives
Memorial Sloan Kettering Cancer Centertech

New Lung Cancer Treatments Aim To Reduce Deaths and Improve Lives

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQelFfa3hVanFWXzlZTFRxVXRZSmMySHJSWFZBdGxndTNuYzM1T1c5eGNVYnhJbFRlU0VmRFBld0VEZlRYeHRGVjQtTDNfaTRWaVlMaGdlR052SUpILU5NWG9yTGEwTVA0Uk1PR2UxOWV6OV9Jd19rcGxvSVZBZ0pYTVpFT24wV2NKWkxBb3UxZFpTNnlWTVBoaQ?oc=5" target="_blank">New Lung Cancer Treatments Aim To Reduce Deaths and Improve Lives</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Naturally occurring molecule may help outsmart melanoma
University of Californiageneral

Naturally occurring molecule may help outsmart melanoma

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPaVRmV0JURW5WcWpCeTE1bEk3bms1R0hFOFBkb292VVlFa1I5Q2MtSnVNeVdCWTJWYzZxcnVSRHZsdVpCUThDNWl0NlJJMmdWN0cyMHh0WDc2VkdDNktTNGxnNkt2blpkQVdsd2lHWXFkNHhWalRheUVSWkNsWGF6WGI3Q2VHRG9hcFZDcEZuVWtOcHFzVVhpa1pDc3BObGdQ?oc=5" target="_blank">Naturally occurring molecule may help outsmart melanoma</a>  <font color="#6f6f6f">University of California</font>

Unlocking the potential of targeting the angiotensin II type 1 receptor in cancer - Oncogene
Natureworld

Unlocking the potential of targeting the angiotensin II type 1 receptor in cancer - Oncogene

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE16VlRkU0JZajRUWk5xcEdGYzgyVUx0ZUpKUWRCMkpTQ2pybk5pMnBVUGZ2M1F1VnJveUh5Sm1YNVFZNFFLMk5veVhWRmFrQ1ptQmJzM1dLeGNfSFdBeF9R?oc=5" target="_blank">Unlocking the potential of targeting the angiotensin II type 1 receptor in cancer - Oncogene</a>  <font color="#6f6f6f">Nature</font>

Next-generation TREM2-targeted therapies for Alzheimer's disease: insights and directions from the INVOKE-2 trial
Frontiersgeneral

Next-generation TREM2-targeted therapies for Alzheimer's disease: insights and directions from the INVOKE-2 trial

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQVzZHVURILXNuTWRvWTlDUXk4VTg3S3NCbWt2RXp1YTJwRmFkb0o2TWNBSlllWGRGX3NrZE1nNXNGWFBQUFNRdTJzNUJad2E3OEg5U0xqdTdOSFdaOUFwRVRITWNRVVNSaF9qMmVoWTNYbHRiQzdJdVlka3JFT1lxS0J5bUxQQWtLMzFwQkxtT3VtQmhieFhSOHhTcmc?oc=5" target="_blank">Next-generation TREM2-targeted therapies for Alzheimer's disease: insights and directions from the INVOKE-2 trial</a>  <font color="#6f6f6f">Frontiers</font>

Stimulating the brain with electromagnetic therapy after stroke may help reduce disability
www.heart.orgtech

Stimulating the brain with electromagnetic therapy after stroke may help reduce disability

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxONTliOUhUUHBfNXRJcFItMHUzOF9TYllicVREV3hIeXdpbGZmTjdMLXhHaVI1WWRTWm5GMTJZMm9MQW8wU0lHSXRpazJrTDQ1QkRPbG1hZ3c4WGhROXB2RDJUa1hfQTgyNnlUTFhsOGVzbGFrMldlZFpiTUtMc2diMGJ0SGx2WnRqNi1jVWwweXhnMGNLd05QUlczekhCZ3pEZ19LWGtMODBmalk0OHZMQVJxamtISXBzQkJvYWV3TQ?oc=5" target="_blank">Stimulating the brain with electromagnetic therapy after stroke may help reduce disability</a>  <font color="#6f6f6f">www.heart.org</font>

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia
Naturegeneral

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5vY0x2UVRZby1FQ0thVGNyQ0pYWGtFdjhGZmQ0TS1wU3ZPbjlDVXpwT1dwNnRfTmNEbURpeGo4VzB5MXh0UHU4ODRIMjJVSDh2cDhBV2k1cEZQZU1IUnNB?oc=5" target="_blank">Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia</a>  <font color="#6f6f6f">Nature</font>

Recent trends in gene-targeted therapies and their influence on surgical decision-making in rheumatoid arthritis affecting the hands, feet, and ankles
Frontiersgeneral

Recent trends in gene-targeted therapies and their influence on surgical decision-making in rheumatoid arthritis affecting the hands, feet, and ankles

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPQlJ6U01LY3AxTlk1YXg4SDk0dm1kU3JGWG9HbVR0dGlkYm1FeGNPVU1mbi1pLWlBSnk2X1hib1FTNi1UdnB6ZmhVVElFMkJkemRxWDNOOU1WbWhIbkJ4Mms1T2hPT0pONklTbHctSXlpeVVRN0taR0ZZRkVtU2tvbm9QdlpFUzl1WEpHNktB?oc=5" target="_blank">Recent trends in gene-targeted therapies and their influence on surgical decision-making in rheumatoid arthritis affecting the hands, feet, and ankles</a>  <font color="#6f6f6f">Frontiers</font>

Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research
Naturegeneral

Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CNmxXSXdyWWQzMWEwc3ltdUltYmlIVmFWSElaTEVKOFlULXpmTDI5V0RwQWZxRFVuZ0p5aVRaYWllVHc2UmdJXy1QSFVsM1J3MWg0aGV4YVVTZEFtOC1B?oc=5" target="_blank">Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research</a>  <font color="#6f6f6f">Nature</font>

Cold and hot tumors: from molecular mechanisms to targeted therapy | Signal Transduction and Targeted Therapy
Naturegeneral

Cold and hot tumors: from molecular mechanisms to targeted therapy | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBVVHVsa2lLVVpWUUNUbVRRRFJFZFNuR0FxSFB3RmZsRTZVNW1FRVk5WTc3cklpXzRLTlpYNWJsOFJvTE96ODYyY0hoLXdmaVZCdm9QcDBveDNKZFhzZUR3?oc=5" target="_blank">Cold and hot tumors: from molecular mechanisms to targeted therapy | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths
Cancer Therapy Advisorworld

Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNVkRlUVJ4dUZNOFdsdG1LM2lMNlBNZ29kbFZ0d1pSSTYxUERwSDZLNjBab1ZhSXhsakloV3RtUGIxUGhpTnJFQWRrU0lKS2xlb0ZiOUVJU0dpWklQc0tfMEtwajVDX2RXbXJ4cW1ldV96T0hROTRrODZYTzV5WnhfLUVPSFVqemUwMy1oY2RvSEJpWl9lOC1JWnVlVnh0amo1WVpvZndodEdEVWFPT2FQUkhSWXRfZw?oc=5" target="_blank">Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse
Roswell Park Comprehensive Cancer Centergeneral

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPQUNOLWtaSWhzME5NbklCRWU3Vk5WdFRSTlJFUk1CUUVXUGo1Nm51eW53UEc4TVNiSVN1VV9wQTRvdFBiQ2dWSjBQaEVTSTl6T3FObG5waWp0N3doMGluckl4V2NGNERIX3VTUVRlNzU4bUg0S2R6V2xObi0zYk9mb3h1Y0J4UjhKdUdDTHlZOUlLbGxQVXU3cV91TXJtRkZjLU5pT203bWVTZEVlU1JZbk1rUnlkRWZQcjc4anVR?oc=5" target="_blank">Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse</a>  <font color="#6f6f6f">Roswell Park Comprehensive Cancer Center</font>

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies
Natureworld

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9yb1U4V0s2Rl9PTjh4bmxwV2cyenNSUW50RXIwQkU5Ml9XMjg4ekZLdTVnLWNsdnB4WDNudUlIUF94dXJPaTh6eUVnTzlfc2FqV1dJbGl2ZHpGd19IdmdB?oc=5" target="_blank">Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies</a>  <font color="#6f6f6f">Nature</font>

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Naturegeneral

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzaENrZzNxWmpJeWdXVnBVOWF0bnBCVjVRbXNQajFNejBHZ2thUGxlZTlBUTByaVdoTlJQLWh5OUJIZHFBSkdZNmlzOWtPZ0JCaGRqYVhoRHhkRklkbG5R?oc=5" target="_blank">Antibody drug conjugate: the “biological missile” for targeted cancer therapy</a>  <font color="#6f6f6f">Nature</font>

Emerging trends in lung cancer research
Abcamworld

Emerging trends in lung cancer research

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxPMFhiR2ZmNkt2VHhyNkNjRlROYnRHVjBLRTRHNW91M1owajB2ckk1WlYxR2Vfd0M5Ri0yaUxmaXNIT1M1bnZ4X2Q0U180dXVGUkkzVXUzaVpuTHl2UjBrOEZ0eTZmRGJpTkVwMnliRGhOR0RSTkhKcjRUeVlFVEx4WHJBS21hTGF6a1BWMA?oc=5" target="_blank">Emerging trends in lung cancer research</a>  <font color="#6f6f6f">Abcam</font>

Targeted Therapies for Mesothelioma
Mesothelioma.netgeneral

Targeted Therapies for Mesothelioma

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE9saUZrempucWlockZuR09IbmhGYkx4NXNYV3R4bjFUb1JtNlMteHpFTlhEekdZOUlGa3NkRXg3QV9meWExSUtQN3NteW01X3JPQlNCUWpZbS00MWFZQ0V0Z1Fud0xyOTFkTGZfVHZ3WjdzaU5QNWplOHRVcw?oc=5" target="_blank">Targeted Therapies for Mesothelioma</a>  <font color="#6f6f6f">Mesothelioma.net</font>

New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function
Memorial Sloan Kettering Cancer Centertech

New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSFA3cXhETlFkRmhTWlIyS0g1ZTFUTTRnRjRBWjFQdHAzMlM5Z3U5VmhPS0Jrc2ZMbkRLaXctOE5OWFhDQ3VoS0tsTTdoYVFrYW1BZ0hleVhvQWM3cmF2WENzaUtrczQ5ZkNKWlRzcTV0cHVqRmZvSUJoM05wMTFZWi1Wb0VDUnEwUlpzdjNLYkJrUXNQMjRQbl84R2J2YktwenFQc1VYWUY2MjFkajE2REROb0c2OEps?oc=5" target="_blank">New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Targeting fatty acid oxidation enhances response to HER2-targeted therapy
Naturegeneral

Targeting fatty acid oxidation enhances response to HER2-targeted therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0xU1dJUW5xamtHRkdaQTRXZHZiSG5UUWd5RU5jbEc2ZlVKNy1VNUlJQ3FFVjUzZnN3RU1ibjVZaG1wd19BODNoR1RGT2NhV2tzY3VEYXppSmpGVmw3WGxr?oc=5" target="_blank">Targeting fatty acid oxidation enhances response to HER2-targeted therapy</a>  <font color="#6f6f6f">Nature</font>

Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy
Naturegeneral

Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBQMFNQNmgzckJRZWtraDhfUjhJY1EzVWFwSU50azNlbTczTXlvRnRjTWdhY2lGaGRIeGcxMFM1RkNXZ1FnaUJBUGlnclkyMDlleXkyVDg5YkZWcHJrRzRj?oc=5" target="_blank">Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
Naturetech

Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1NYmhadlBualY3ckRXS016WkRaQWtqelZDM25BOVY4MzF4aGFoZFpoeEFrbnFLUzUyQmJ5bFQtdTh1aWpGb1loaE80UWN1ZW1sRnhLUVU5WVhPU2F0dkc4?oc=5" target="_blank">Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy</a>  <font color="#6f6f6f">Nature</font>

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence
UCLA Healthgeneral

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNd0V0dlpDenhlWWU5UWg5Wk5kMVdPTlgyUnhfVHVIZllta3ZzYk1xbUt3WWFtUm52MGt6VWtyYmxkMW42eV9ZXzVtZWRkU1c4dTFZSkpnRUpqdDFaR09xTVJWWl84WC1uUGIxWG9FV2hSS1JQemcwLTA2T3A3TVNPSzlWRjJnQVJXUWxWek9XZFluU0lyemJhX1d4Q01aTnc4Znc?oc=5" target="_blank">Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence</a>  <font color="#6f6f6f">UCLA Health</font>

"Targeted therapy reduces" — Live Google News Trends & Headlines